Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Blanchard, Barbara J. | Hiniker, Anne E. | Lu, Connie C. | Margolin, Yelena | Yu, Amy S. | Ingram, Vernon M.; *
Affiliations: Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Correspondence: [*] Corresponding author: Dr V.M. Ingram, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA, E-mail: [email protected]
Abstract: Aggregation of the Alzheimer amyloid β peptide (Aβ) Ab1-42 forms neurotoxic fibrils. In contact with human neurons the fibrils cause rapid influx of external calcium through AMPA/kainate-channels. If this molecular mechanism reflects in vivo events, it could explain the pathogenesis of Alzheimer's disease; activation of AMPA/kainate channels is therefore a likely target for therapeutic intervention. Here we show that short antagonistic “decoy peptides”, made of D-amino acids, eliminate this “calcium effect” of Ab1-42. Since chronically elevated calcium levels in the disease trigger activation of pathways that lead to neuron dysfunction and cell death, our decoy peptides are obvious candidates for drug development.
DOI: 10.3233/JAD-2000-2214
Journal: Journal of Alzheimer's Disease, vol. 2, no. 2, pp. 137-149, 2000
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]